echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Be careful! Some contents of the outline of the qualification examination for licensed pharmacists have been adjusted

    Be careful! Some contents of the outline of the qualification examination for licensed pharmacists have been adjusted

    • Last Update: 2019-04-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In order to do a good job in the national licensed pharmacist qualification examination in 2019, entrusted by the State Drug Administration, the National Drug Administration licensed pharmacist qualification certification center, in accordance with the relevant provisions of the national licensed pharmacist qualification examination program (Seventh Edition) (hereinafter referred to as the program), determines the content adjustment of the program of drug administration and regulations in the 2019 licensed pharmacist qualification examination Matters concerned After examination and approval, it is hereby announced as follows In principle, the newly issued or revised drug administration laws and regulations will not be included in this year's examination contents and topics between the issuance of this circular and this October's examination 1、 The examination contents of the detailed items and key points of the subject of Chinese medicine administration and regulations in the outline, involving the following new policies and regulations, shall be mastered in accordance with the provisions of the new policies: (1) laws and decisions adopted by the National People's Congress and its Standing Committee after deliberation; (1) decision of the first session of the 13th National People's Congress on the institutional reform plan of the State Council 2 Decision of the Standing Committee of the National People's Congress on the extension of the pilot period of authorizing the State Council to carry out the system of drug listing license holders in some places (adopted at the 6th meeting of the Standing Committee of the 13th National People's Congress on October 26, 2018) 3 The advertisement law of the people's Republic of China (adopted at the 10th meeting of the Standing Committee of the Eighth National People's Congress on October 27, 1994, revised at the 14th meeting of the Standing Committee of the Twelfth National People's Congress on April 24, 2015, in accordance with the amendment of the "amendment of the people's Republic of China" issued at the 6th meeting of the Standing Committee of the Thirteenth National People's Congress on October 26, 2018 The decision of 15 laws, such as the animal protection law, was amended (2) Administrative regulations and relevant provisions issued by the State Council 1 Documents related to the allocation and adjustment of functions of ministries and bureaus related to drug safety supervision in the institutional reform of the State Council in 2018 2 Decision of the State Council on amending some administrative regulations (Order No 703 of the State Council) 3 Decision of the State Council on amending some administrative regulations (Order No 709 of the State Council) 4 Opinions of the general office of the State Council on reforming and improving the supply guarantee and use policy of generic drugs (GBF [2018] No 20) 5 Opinions of the general office of the State Council on improving the national basic drug system (GBF [2018] No 88) (3) Departmental rules and regulations issued by the State Administration of market supervision, the State Health Commission, the Ministry of human resources and social security and the State Drug Administration 1 Notice of the Ministry of human resources and social security of the State Food and Drug Administration on printing and distributing the provisions of the professional qualification system for licensed pharmacists and the measures for the implementation of the professional qualification examination for licensed pharmacists (Guo Yao Jian Ren [2019] No 12) 2 Notice on continuous management of clinical application of antibacterial drugs (gwbf [2018] No.9) 3 Notice on printing and distributing the prescription audit specifications of medical institutions (gwb-yf [2018] No 14) 4 Opinions on accelerating the high-quality development of pharmaceutical care (gwyf [2018] No 45) 5 Notice on printing and distributing the catalogue of national essential drugs (2018 Edition) (gwyzf [2018] No 31) 6 Notice on the management of clinical application of auxiliary drugs (GWB YH [2018] No 1112) 7 Administrative measures for monitoring and reevaluation of adverse events of medical devices (Order No 1 of the State Administration of market supervision) 8 Decision of the State Administration of market supervision on Amending the three regulations including the measures for the examination of drug advertisements (Order No 4 of the State Administration of market supervision) 9 Announcement of the State Drug Administration on the release of the administrative provisions on simplified registration and approval of ancient classical Chinese herbal compound preparations (No 27, 2018) 10 Notice of the State Drug Administration on matters related to the conformity evaluation of quality and efficacy of generic drugs (No 102, 2018) 11 Regulations on the establishment of internal organizations and personnel for the main responsibilities of public institutions affiliated to the State Drug Administration (gyjz [2018] No 60) 12 Guidance of the State Food and Drug Administration on the construction of drug information traceability system (gjjg [2018] No 35) 2、 The specific contents of the adjustment of the outline, such as the regulations on the professional qualification system of licensed pharmacists, the opinions on reforming and improving the supply guarantee and use policy of generic drugs, and the notice on doing a good job in the clinical application management of auxiliary drugs, are not required in the original outline and need to be adjusted accordingly The adjustment contents are as follows: (1) in the first unit and the first small unit of the first large unit, add the fifth sub item "supervision and management of licensed pharmacists' practice activities" and the key points "contents of supervision and inspection", "handling of illegal and illegal participation in qualification examination, non-compliance with the provisions of registration and" registration " (2) In the second unit of the second unit, add the fourth sub item "reform and improvement of supply guarantee and use policy of generic drugs" and the main points "opinions on reform and improvement of supply guarantee and use policy of generic drugs" (3) In the corresponding key points of the second detail of the first unit of the third unit, change "responsibilities of health and family planning department" to "responsibilities of health department", "responsibilities of industrial and commercial administration department" to "responsibilities of market supervision department", and add "responsibilities of medical security department" (4) In the fifth unit, the second unit, the fifth detail, add the key point "clinical application management of auxiliary drugs" (5) In the fourth unit of the sixth unit, add the details of "management of ancient classic and famous traditional Chinese medicine compound preparation" and key points of "catalogue of ancient classic and famous traditional Chinese medicine compound preparation" and "management requirements of ancient classic and famous traditional Chinese medicine compound preparation" (see Annex) Notice is hereby given Appendix: contents of drug administration and regulation subject adjustment of national licensed pharmacist qualification examination outline in 2019 contents of drug administration and regulation subject adjustment of national licensed pharmacist qualification examination outline in 2019
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.